Natalie J. Thornburg, Ph.D.
Affiliations: | 2004 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Microbiology Biology, Molecular Biology, Cell BiologyGoogle:
"Natalie Thornburg"Parents
Sign in to add mentor| Nancy J. Raab-Traub | grad student | 2004 | UNC Chapel Hill | |
| (Functional analysis of Epstein-Barr viral genes expressed in nasopharyngeal carcinoma.) | ||||
| James Earl Crowe, Jr. | post-doc | 2007-2012 | Vanderbilt Medical School (ID Tree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tartof SY, Xie F, Yadav R, et al. (2023) Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Influenza and Other Respiratory Viruses. 17: e13143 |
| Dawood FS, Tita A, Stockwell MS, et al. (2023) Neutralizing Antibody Responses to Messenger RNA Coronavirus Disease 2019 Vaccines Versus Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Pregnant Women and Vaccine-Induced Antibody Transfer to Infants. Open Forum Infectious Diseases. 10: ofad204 |
| Tartof SY, Xie F, Yadav R, et al. (2023) Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network. Medrxiv : the Preprint Server For Health Sciences |
| Herring MK, Romine JK, Wesley MG, et al. (2022) SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
| Kuhn JH, Adkins S, Alkhovsky SV, et al. (2022) 2022 taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Archives of Virology |
| Tobolowsky FA, Waltenburg MA, Moritz ED, et al. (2022) Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021. Plos One. 17: e0275718 |
| Ngere I, Hunsperger EA, Tong S, et al. (2022) Outbreak of Middle East Respiratory Syndrome Coronavirus in Camels and Probable Spillover Infection to Humans in Kenya. Viruses. 14 |
| Wang L, Kainulainen MH, Jiang N, et al. (2022) Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines. Nature Communications. 13: 4350 |
| Stumpf MM, Freeman B, Mills L, et al. (2022) Examination of Common Coronavirus Antibodies in SARS-CoV-2-Infected and Uninfected Participants in a Household Transmission Investigation. Open Forum Infectious Diseases. 9: ofac212 |
| Schuh AJ, Satheshkumar PS, Dietz S, et al. (2022) SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection. Microbiology Spectrum. e0124722 |